PL420907A1 - Composition in the form of gel - Google Patents

Composition in the form of gel

Info

Publication number
PL420907A1
PL420907A1 PL420907A PL42090717A PL420907A1 PL 420907 A1 PL420907 A1 PL 420907A1 PL 420907 A PL420907 A PL 420907A PL 42090717 A PL42090717 A PL 42090717A PL 420907 A1 PL420907 A1 PL 420907A1
Authority
PL
Poland
Prior art keywords
composition
subject
application
gel
joint
Prior art date
Application number
PL420907A
Other languages
Polish (pl)
Other versions
PL235088B1 (en
Inventor
Artur WILANDT
Krzysztof Lemke
Jan PROCEK
Original Assignee
Biovico Spolka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovico Spolka Z Ograniczona Odpowiedzialnoscia filed Critical Biovico Spolka Z Ograniczona Odpowiedzialnoscia
Priority to PL420907A priority Critical patent/PL235088B1/en
Priority to PCT/PL2018/000028 priority patent/WO2018182436A2/en
Publication of PL420907A1 publication Critical patent/PL420907A1/en
Publication of PL235088B1 publication Critical patent/PL235088B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Abstract

Przedmiotem zgłoszenia jest nowa kompozycja zawierająca kwas hialuronowy, fosfolipidy, rozpuszczalne związki krzemu do zastosowania w układzie buforującym. Przedmiotem zgłoszenia jest również zastosowanie kompozycji do leczenia bólu stawów, uszkodzeń stawów/ścięgien, zapaleniu stawów w tym Reumatoidalnego Zapalenia Stawów (RZS), oraz jako induktor kolagenu, wypełniacz kosmetyczny.The subject of the application is a new composition containing hyaluronic acid, phospholipids, soluble silicon compounds for use in a buffering system. The subject of the application is also the use of the composition for the treatment of joint pain, joint / tendon damage, arthritis including Rheumatoid Arthritis (RA), and as a collagen inducer, a cosmetic filler.

PL420907A 2017-03-20 2017-03-20 Composition in the form of gel PL235088B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL420907A PL235088B1 (en) 2017-03-20 2017-03-20 Composition in the form of gel
PCT/PL2018/000028 WO2018182436A2 (en) 2017-03-20 2018-03-20 A composition in the form of a gel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL420907A PL235088B1 (en) 2017-03-20 2017-03-20 Composition in the form of gel

Publications (2)

Publication Number Publication Date
PL420907A1 true PL420907A1 (en) 2018-09-24
PL235088B1 PL235088B1 (en) 2020-05-18

Family

ID=62530522

Family Applications (1)

Application Number Title Priority Date Filing Date
PL420907A PL235088B1 (en) 2017-03-20 2017-03-20 Composition in the form of gel

Country Status (2)

Country Link
PL (1) PL235088B1 (en)
WO (1) WO2018182436A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021121566A1 (en) * 2019-12-17 2021-06-24 Aa Healthcare Sàrl Utilization of a composition comprising organic silica for the improvement of the quality of cartilagenous tissues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1552839A4 (en) * 2002-08-16 2011-11-02 Denki Kagaku Kogyo Kk Separate type medical material
US9216164B2 (en) * 2009-07-23 2015-12-22 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
RU2473352C2 (en) * 2011-04-21 2013-01-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Intra-articular fluid simulator formulation and method for preparing intra-articular fluid additive
US10646574B2 (en) * 2014-07-21 2020-05-12 Board Of Regents, The University Of Texas System Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same

Also Published As

Publication number Publication date
WO2018182436A3 (en) 2018-12-20
PL235088B1 (en) 2020-05-18
WO2018182436A2 (en) 2018-10-04

Similar Documents

Publication Publication Date Title
CR20200064A (en) Carboxamides as modulators of sodium channels
PH12015502792A1 (en) Crystalline bromodomain inhibitors
EA200802135A1 (en) PHARMACEUTICAL COMPOSITIONS OF ANTAGONISTIC ANTIBODY TO CD40
MX360833B (en) Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use.
PH12019502646A1 (en) Pyrazole magl inhibitors
DK2126049T3 (en) Human cytomegalovirus (hCMV) antibodies
PH12020551057A1 (en) Group b adenovirus-containing formulation
MX2022002946A (en) Cdk inhibitors and their use as pharmaceuticals.
PH12019502548A1 (en) Pyrazole magl inhibitors
MX2019008544A (en) Novel stable formulation for fxia antibodies.
MX2022013566A (en) Antibody.
EA201891610A1 (en) DERIVATIVES 3- (CARBOXYETHYL) -8-AMINO-2-OXO-1,3-DIAZASPIRO [4.5] DEAN
EA201590601A1 (en) APPLICATION OF PEDF-DERIVED POLYPEPTIDES FOR THE TREATMENT OF OSTEOARTHRITIS
JOP20200069A1 (en) Anti-pacap antibody
CR20210021A (en) Solubilized apyrases, methods and use
MX2020007760A (en) Compositions and methods of enhancing 5-hydroxytryptophan bioavailability.
PL420907A1 (en) Composition in the form of gel
MX2017010277A (en) Cenicriviroc for the treatment of fibrosis.
MX2019010218A (en) Pyrazole derivatives as bromodomain inhibitors.
SG10201802129QA (en) A pharmaceutical composition for neuropathic pain
EA202091062A1 (en) CARBOXYLCHITOSAN
EA201991395A1 (en) NEW COMPOSITIONS FOR TREATMENT OF JOINT VIOLATIONS
PL424999A1 (en) Pharmaceutically acceptable 5-(4-chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
EA202090268A1 (en) CARBOXAMIDS AS SODIUM CHANNEL MODULATORS
UA126148U (en) METHOD OF TREATMENT OF PERIAMPLANT MUCOSITE